Form 4 Tracker
Mark Anthony Tyndall

EVP & CLO and Corp Sec · 1 filing · Latest: Feb 25, 2026

Keenova Therapeutics plc
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing